Lefno is indicated for the treatment of adult patients with: active rheumatoid arthritis as a "disease-modifying antirheumatic drug" (DMARD); active psoriatic arthritis.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education